Oracle stock fell 6% after hitting a record high of $328.33 the day before

來源 Cryptopolitan

Oracle tumbled by 6% on Thursday after touching an all-time high just a day before. The drop came fast after a brutal reality check: nearly all of its hyped growth is tied to just one client, OpenAI, as Cryptopolitan reported.

The sharp reversal hit right after CEO Safra Catz told investors on Tuesday that Oracle had locked in “four multi-billion-dollar contracts with three different customers.”

That announcement pushed shares up 30% in after-hours trading, followed by another spike that closed Wednesday with a record high of $328.33.

But as soon as the market learned that most of the backlog might be coming from OpenAI, the gains vanished. Analyst Gil Luria, who holds a neutral rating on Oracle, issued a note Thursday warning that:

“Our enthusiasm for Oracle’s backlog announcements is significantly tempered by the report that it came almost entirely from OpenAI.”

The $300 billion five-year agreement between the two companies was revealed on Wednesday and left investors with more questions than answers. Oracle didn’t comment. OpenAI didn’t either.

Gil Luria questions Oracle’s real growth story

Safra said Oracle’s remaining performance obligation had surged to $455 billion, which is 359% more than the same time last year. That number sounds impressive until you realize how much of it may be from a single buyer.

And it’s not just a one-off contract. OpenAI also agreed to build 4.5 gigawatts of data center capacity in the U.S., a deal that directly benefits Oracle’s cloud infrastructure rollout.

Inside Oracle’s forecasts, the company expects its cloud infrastructure revenue to grow 14 times larger by 2030. But with so much pinned to OpenAI, even a small delay or shift in that partnership could wreck that entire projection. That’s why Gil’s warning mattered, and why the market dumped the stock.

Global markets surge as Fed rate cuts look likely

While Oracle tanked, the rest of the equity market stayed hot. Stocks across the globe hit new records this week as traders bet on rate cuts. The MSCI All Country World Index reached fresh highs for the fourth day in a row, tracking over 2,500 companies from both developed and emerging markets.

In the U.S., the S&P 500 closed at another record on Wednesday, backed by optimism that the Federal Reserve will start easing. That came after the U.S. producer price index dropped 0.1% in August, a huge surprise since Wall Street expected a 0.3% increase. The sudden weakness in wholesale prices gave investors more reason to believe that the Fed is ready to cut.

Eddy Loh, head of investment strategy at Maybank, said, “Markets have been a bit more resilient than what we’ve been expecting.” He added that the rally is fueled by strong corporate earnings and solid growth, not just in the U.S., but also in Europe, Japan, and major Asian markets.

The CME FedWatch tool now shows a 92% chance of a 25-basis-point cut at the Fed’s next meeting on September 17. That shift in sentiment also triggered risk-on behavior across Asia, where Japan’s Nikkei 225, South Korea’s Kospi, and Singapore’s Straits Times Index all broke records this week.

Marvin Loh, senior global macro strategist at State Street, said, “Given that we are building a stronger case for the Fed to restart its cutting cycle while the economy remains on a fairly solid footing, this environment serves as a tonic for risk investors.”

But none of that helped Oracle on Thursday. Investors took their gains and left once it became clear that the company’s future growth was riding on just one name.

Sign up to Bybit and start trading with $30,050 in welcome gifts

免責聲明:僅供參考。 過去的表現並不預示未來的結果。
placeholder
黃金七連漲終結!是上車機會還是牛市拐點?​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
作者  投資-槓把子
9 月 05 日 週五
​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
placeholder
康霈*澄清來得太遲!1.5萬張賣單說明一切:一場由減肥藥夢碎引發的踩踏遠未結束生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
作者  投資-槓把子
9 月 10 日 週三
生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
placeholder
日幣匯率巨震!日本央行10月升息機率大增,日幣未來或升值至142?政治動盪不改日本央行升息立場,對沖基金大舉買進日幣看漲期權。
作者  Tony Chou
9 月 10 日 週三
政治動盪不改日本央行升息立場,對沖基金大舉買進日幣看漲期權。
placeholder
黃金、白銀繼續衝高,澳新銀行:2025年底金價將漲至3800美元!2025年底,金價有望漲至3800美元,銀價可望漲至50美元。
作者  Tony Chou
9 月 10 日 週三
2025年底,金價有望漲至3800美元,銀價可望漲至50美元。
placeholder
生技股王殞落! FDA重擊+內部人狂賣,康霈*遭連續兩日跌停康霈*生技新藥研發進程突生變數,引發市場劇烈反應。這家不久前剛被納入台灣五十指數成分股的生技明星企業,在9月9日法說會上宣布,其核心產品減肥注射劑CBL-514的臨床三期試驗將延後約半年收案,導致公司股票連續兩個交易日跌停,市值蒸發400億元,跌停板委賣張數累計超過3萬張。
作者  投資-槓把子
21 小時前
康霈*生技新藥研發進程突生變數,引發市場劇烈反應。這家不久前剛被納入台灣五十指數成分股的生技明星企業,在9月9日法說會上宣布,其核心產品減肥注射劑CBL-514的臨床三期試驗將延後約半年收案,導致公司股票連續兩個交易日跌停,市值蒸發400億元,跌停板委賣張數累計超過3萬張。
goTop
quote